These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7184437)

  • 1. [Experimental and clinical studies of bestatin as an immunomodulator].
    Miwa H; Oka T; Tsurumi T; Sakae Y; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1019-24. PubMed ID: 7184437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bestatin administration and the change in cellular immunity.
    Yamagishi H; Naito K; Ueda Y; Itoi S; Kohnosu H; Kobayashi M; Kubo H; Matsuda A; Oka T
    Biomed Pharmacother; 1991; 45(2-3):117-20. PubMed ID: 1912367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory and therapeutic properties of bestatin in mice.
    Talmadge JE; Lenz BF; Pennington R; Long C; Phillips H; Schneider M; Tribble H
    Cancer Res; 1986 Sep; 46(9):4505-10. PubMed ID: 2942238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of gastrointestinal cancer patients with levamisole.
    Miwa H; Orita K
    Acta Med Okayama; 1979 Feb; 33(1):29-42. PubMed ID: 155980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low molecular weight immunomodulators produced by microorganisms].
    Ishizuka M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bestatin treatment and the peripheral lymphocyte population in cancer patients.
    Blomgren H; Strender LE; Edsmyr F
    Recent Results Cancer Res; 1980; 75():133-8. PubMed ID: 7232824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study.
    Blomgren H; Strender LE; Edsmyr F
    Biomedicine; 1980 Dec; 32(4):178-85. PubMed ID: 7470579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight immunomodifiers produced by microorganisms.
    Umezawa H; Ishizuka M
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bestatin treatment enhances the recovery of radiation induced impairments of the immunological reactivity of the blood lymphocyte population in bladder cancer patients.
    Blomgren H; Edsmyr F; von Stedingk LV; Wasserman J
    Biomed Pharmacother; 1986; 40(2):50-4. PubMed ID: 3756312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
    Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Bestatin, a new immunomodulator, on various functions of human monocytes.
    Jarstrand C; Blomgren H
    J Clin Lab Immunol; 1982 Dec; 9(3):193-8. PubMed ID: 7166751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients.
    Miwa H; Orita K
    Acta Med Okayama; 1977 Oct; 31(5):325-9. PubMed ID: 146404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of small molecular microbial products modulating immune responses and bestatin.
    Umezawa H
    Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bestatin, a new immunomodulator, augments the release of mitogenic factors from PHA-stimulated human lymphocytes.
    Blomgren H
    Biomedicine; 1981 Dec; 34(4):188-92. PubMed ID: 6979352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bestatin treatment of patients with myelodysplastic syndromes].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):365-70. PubMed ID: 2930201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial.
    Blomgren H; Edsmyr F; Esposti PL; Näslund I
    Biomed Pharmacother; 1984; 38(3):143-9. PubMed ID: 6383491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
    Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
    Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.